Finance

Lists
ORCHPHARMA:NSE
Orchid Pharma Ltd
₹958.00
+2.50%
(+23.35) 1D
Sep 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ORCHPHARMA...
Open
₹937.00
High
₹965.45
Low
₹934.70
Mkt. cap
57.37B
Avg. vol.
0.00
Volume
41.66K
P/E ratio
618.64
52-wk high
₹1,133.00
52-wk low
₹480.00
EPS
₹1.55
No. of employees
736
Open
₹937.00
High
₹965.45
Low
₹934.70
Mkt. cap
57.37B
Avg. vol.
0.00
Volume
41.66K
P/E ratio
618.64
52-wk high
₹1,133.00
52-wk low
₹480.00
EPS
₹1.55
No. of employees
736
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees736
Founded1992
Headquarters-
SectorPharmaceutical industry
Last report
Aug 21, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹0.54 / ₹3.60
-85.00%miss
Revenue / Est. (INR)
3.04B / 2.30B
+31.96%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-2.96%
-6.09%
7.02%
1.06%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps